These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 24726808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S, Parveen S, Hao X, Zhang S, Wang W, Qin X, Yang Y, Chen X, Zhu S, Zhu C, Ma B.
    Eur J Med Chem; 2014 Jun 10; 80():383-92. PubMed ID: 24793885
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
    Ji Y, Chen X, Chen H, Zhang X, Fan Z, Xie L, Ma B, Zhu C.
    Bioorg Med Chem; 2019 Apr 15; 27(8):1658-1669. PubMed ID: 30858026
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
    Wu B, Yang Y, Qin X, Zhang S, Jing C, Zhu C, Ma B.
    ChemMedChem; 2013 Dec 15; 8(12):1913-7. PubMed ID: 24115741
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of quinoxalin-2(1H)-one derivatives as a novel class of multifunctional aldose reductase inhibitors.
    Hao X, Qin X, Zhang X, Ma B, Qi G, Yu T, Han Z, Zhu C.
    Future Med Chem; 2019 Dec 15; 11(23):2989-3004. PubMed ID: 31659919
    [Abstract] [Full Text] [Related]

  • 9. An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase.
    Yang Y, Zhang S, Wu B, Ma M, Chen X, Qin X, He M, Hussain S, Jing C, Ma B, Zhu C.
    ChemMedChem; 2012 May 15; 7(5):823-35. PubMed ID: 22416050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G, Ferrari AM, Costantino L, Gamberini MC.
    Bioorg Med Chem; 2002 May 15; 10(5):1437-50. PubMed ID: 11886806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
    Reddy TN, Ravinder M, Bagul P, Ravikanti K, Bagul C, Nanubolu JB, Srinivas K, Banerjee SK, Rao VJ.
    Eur J Med Chem; 2014 Jan 15; 71():53-66. PubMed ID: 24275248
    [Abstract] [Full Text] [Related]

  • 20. Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors.
    Saito R, Hoshi M, Kato A, Ishikawa C, Komatsu T.
    Eur J Med Chem; 2017 Jan 05; 125():965-974. PubMed ID: 27769036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.